Benzinga | Nov 22, 2021 11:54AM EST

EF Hutton Maintains Buy on iSpecimen, Raises Price Target to $12

EF Hutton analyst Constantine Davides maintains iSpecimen (NASDAQ:ISPC) with a Buy and raises the price target from $10 to $12.